PPARG and metabolic dysfunction-associated steatotic liver disease: Since PPARγ expression level is increased in NAFLD, obese, and T2DM patients, it was suggested that PPARγ acts as a pro-steatosis factor via the de novo lipogenesis and activation of lipogenic genes [152,153].